Pharmadrug Inc. (PHRX.CN)
CAD 0.01
(0.0%)
CAD 0.01
(0.0%)
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2023 | -1.33 Million CAD | 45.06% |
| 2022 | -2.42 Million CAD | 52.41% |
| 2021 | -5.1 Million CAD | -33.76% |
| 2020 | -3.81 Million CAD | 25.05% |
| 2019 | -5.09 Million CAD | -53.23% |
| 2018 | -3.32 Million CAD | -2777.4% |
| 2017 | -115.52 Thousand CAD | 98.47% |
| 2016 | -7.55 Million CAD | -952.93% |
| 2015 | -717.41 Thousand CAD | 64.39% |
| 2014 | -2.01 Million CAD | -775.42% |
| 2013 | -230.13 Thousand CAD | -11.82% |
| 2012 | -205.79 Thousand CAD | 0.0% |
| 2011 | - CAD | 0.0% |
| Year | Operating Income | Operating Income Growth |
|---|---|---|
| 2024 Q1 | -449.46 Thousand CAD | 72.53% |
| 2024 Q2 | -62.42 Thousand CAD | 88.39% |
| 2023 Q4 | -1.63 Million CAD | -701.68% |
| 2023 Q1 | -214.14 Thousand CAD | 25.18% |
| 2023 Q2 | -283.47 Thousand CAD | -32.38% |
| 2023 Q3 | -204.13 Thousand CAD | 27.99% |
| 2023 FY | -2.33 Million CAD | 3.77% |
| 2022 Q3 | -582.58 Thousand CAD | -9.04% |
| 2022 Q4 | -286.2 Thousand CAD | 50.87% |
| 2022 FY | -2.42 Million CAD | 52.41% |
| 2022 Q1 | -1.57 Million CAD | -21.98% |
| 2022 Q2 | -534.28 Thousand CAD | 66.16% |
| 2021 Q4 | -1.29 Million CAD | -0.97% |
| 2021 FY | -5.1 Million CAD | -33.76% |
| 2021 Q2 | -1.13 Million CAD | 18.52% |
| 2021 Q3 | -1.28 Million CAD | -12.87% |
| 2021 Q1 | -1.39 Million CAD | -95.62% |
| 2020 Q4 | -712.58 Thousand CAD | 40.21% |
| 2020 Q3 | -1.19 Million CAD | 8.92% |
| 2020 Q2 | -1.3 Million CAD | -116.37% |
| 2020 Q1 | -604.73 Thousand CAD | 79.77% |
| 2020 FY | -3.81 Million CAD | 25.05% |
| 2019 Q3 | -369.14 Thousand CAD | 66.63% |
| 2019 FY | -5.09 Million CAD | -53.23% |
| 2019 Q4 | -2.98 Million CAD | -709.85% |
| 2019 Q2 | -1.1 Million CAD | -33.17% |
| 2019 Q1 | -830.66 Thousand CAD | -291.04% |
| 2018 Q4 | -212.42 Thousand CAD | 63.5% |
| 2018 FY | -3.32 Million CAD | -2777.4% |
| 2018 Q3 | -581.99 Thousand CAD | -1758.03% |
| 2018 Q2 | -31.32 Thousand CAD | 61.23% |
| 2018 Q1 | -80.79 Thousand CAD | -140.09% |
| 2017 Q2 | -23.51 Thousand CAD | 11.46% |
| 2017 Q4 | -33.65 Thousand CAD | -218.53% |
| 2017 Q3 | -10.56 Thousand CAD | 55.06% |
| 2017 FY | -115.52 Thousand CAD | 98.47% |
| 2017 Q1 | -26.55 Thousand CAD | 51.11% |
| 2016 Q3 | -163.69 Thousand CAD | 97.74% |
| 2016 Q1 | -70.74 Thousand CAD | -3.86% |
| 2016 Q2 | -7.25 Million CAD | -10149.99% |
| 2016 FY | -7.55 Million CAD | -952.93% |
| 2016 Q4 | -54.31 Thousand CAD | 66.82% |
| 2015 FY | -717.41 Thousand CAD | 64.39% |
| 2015 Q4 | -68.11 Thousand CAD | -51505.3% |
| 2015 Q3 | -132.00 CAD | 99.91% |
| 2015 Q2 | -141.35 Thousand CAD | 36.31% |
| 2015 Q1 | -221.94 Thousand CAD | 37.3% |
| 2014 Q3 | -784.45 Thousand CAD | -129.94% |
| 2014 Q1 | -524.08 Thousand CAD | -43.62% |
| 2014 FY | -2.01 Million CAD | -775.42% |
| 2014 Q4 | -353.98 Thousand CAD | 54.88% |
| 2014 Q2 | -341.15 Thousand CAD | 34.9% |
| 2013 Q4 | -364.91 Thousand CAD | -234.91% |
| 2013 Q2 | -26.74 Thousand CAD | 56.58% |
| 2013 Q1 | -61.6 Thousand CAD | -88.36% |
| 2013 FY | -230.13 Thousand CAD | -11.82% |
| 2013 Q3 | -108.96 Thousand CAD | -307.39% |
| 2012 FY | -205.79 Thousand CAD | 0.0% |
| 2012 Q3 | -2836.00 CAD | 84.83% |
| 2012 Q2 | -18.69 Thousand CAD | 80.54% |
| 2012 Q1 | -96.05 Thousand CAD | -8.88% |
| 2012 Q4 | -32.7 Thousand CAD | -1053.17% |
| 2011 FY | - CAD | 0.0% |
| 2011 Q4 | -88.21 Thousand CAD | 0.0% |
| Name | Operating Income | Operating Income Difference |
|---|---|---|
| Aion Therapeutic Inc. | -1.19 Million CAD | -12.097% |
| Ayurcann Holdings Corp. | -3.25 Million CAD | 58.934% |
| Blueberries Medical Corp. | -1.22 Million CAD | -8.841% |
| The BC Bud Corporation | -1.22 Million CAD | -9.116% |
| BioNxt Solutions Inc. | -6.36 Million CAD | 79.033% |
| CordovaCann Corp. | -2.51 Million CAD | 46.866% |
| Christina Lake Cannabis Corp. | -880.54 Thousand CAD | -51.612% |
| Captor Capital Corp. | 655.2 Thousand CAD | 303.754% |
| City View Green Holdings Inc. | -996.45 Thousand CAD | -33.977% |
| 1CM Inc. | 300.79 Thousand CAD | 543.834% |
| Global Hemp Group Inc. | -551.7 Thousand CAD | -141.978% |
| Greenway Greenhouse Cannabis Corporation | -3.87 Million CAD | 65.584% |
| IM Cannabis Corp. | -12.17 Million CAD | 89.035% |
| Lobe Sciences Ltd. | -3.35 Million CAD | 60.26% |
| Maple Leaf Green World Inc. | -392.21 Thousand CAD | -240.377% |
| Mountain Valley MD Holdings Inc. | -3.18 Million CAD | 58.098% |
| Nextleaf Solutions Ltd. | 542.27 Thousand CAD | 346.19% |
| Ovation Science Inc. | -764 Thousand CAD | -74.738% |
| Captiva Verde Wellness Corp. | -1.14 Million CAD | -16.904% |
| RAMM Pharma Corp. | -7.08 Million CAD | 81.16% |
| RIV Capital Inc. | 1.78 Million CAD | 174.991% |
| Revive Therapeutics Ltd. | -3.28 Million CAD | 59.373% |
| Red White & Bloom Brands Inc. | -8.76 Million CAD | 84.776% |
| SLANG Worldwide Inc. | -5.98 Million CAD | 77.699% |
| 1933 Industries Inc. | -9.34 Million CAD | 85.721% |
| Red Light Holland Corp. | -6.44 Million CAD | 79.291% |
| Top Strike Resources Corp. | -784.8 Thousand CAD | -70.108% |
| Xebra Brands Ltd. | -1.55 Million CAD | 14.122% |
| Adastra Holdings Ltd. | -1.79 Million CAD | 25.575% |